The platform for the study of Neuroinflammation of the NeuroDiderot laboratory at the Robert Debré Hospital gather a whole set of technology and expertise to study and analyze the inflammatory processes affecting the nervous system.
Neuroinflammation is described as one of the major factors for neurodevelopmental and neurodegenerative diseases. Neuroinflammation is characterized by an increase of glial cells reactivity (microglia and astrocytes), often along with brain-blood barrier permeability and leukocyte infiltration. Characterizing those inflammatory mechanisms in order to understand the influence of those cells and their secreted molecules on cerebral functions represent a major challenge for clinical and experimental researches. Working with a team of experts, researchers and engineers, along with advanced equipment, the platform for the study of Neuroinflammation of the NeuroDiderot laboratory at the Robert Debré Hospital gather a whole set of technology and expertise to study and analyze the inflammatory processes affecting the nervous system.
Neuroinflammation Plateform – NeuroDiderot
Hôpital Robert Debré
48 Bd Sérurier
75019 Paris, France
Juliette Van Steenwinckel, PhD –
Jennifer Hua, PhD –
Sleep2Develop research program
The Sleep2Develop program investigates the role of sleep as a promotor of neurodevelopment and identifies the sleep determinants of childhood development. This is rephrased as Sleep(to)Develop? or Sleep(to)Develop! Our sleep research combines clinical and...
NemoClinics platform is hiring an engineer. Check out the opportunity here: U 1141 -Ingénieur-e en expérimentation et instrumentation biologiques- CDD 2023 Read more
Research program on CCHS
CCHS is a disease characterized by a congenital impairment of the central control of breathing, associated with dysfunctions of the autonomic nervous system (ANS) (Gallego, 2012). At birth, patients have severe and persistent hypoventilation during sleep and a...
Breaking news for Central Congenital Hypoventilation Syndrome
In collaboration with Dr. Muriel Thoby-Brisson (Université de Bordeaux, Institut de Neurosciences Cognitives et Intégratives d’Aquitaine, CNRS), and thanks to Fondation Air Liquide, Association Française du syndrome d'Ondine and start-up company ATMOSR, team NeoPhen...